Psilos Group: Digital Therapeutics — “Software as a Drug” — Is a $6 Billion Potential Market Opportunity Says 2016 Outlook Report

Utilizing Software Modules as an Enhancement to Pharmaceuticals for Chronic Conditions Is Poised to Be Critical Component of Digital Healthcare